Double versus single renal allografts from aged donors

被引:118
作者
Andrés, A
Morales, JM
Herrero, JC
Praga, M
Morales, E
Hernández, E
Ortuño, T
Rodício, JL
Martínez, MA
Usera, G
Díaz, R
Polo, G
Aguirre, F
Leiva, O
机构
[1] Hosp 12 Octubre, Dept Nefrol, E-28041 Madrid, Spain
[2] Hosp 12 Octubre, Dept Pathol, E-28041 Madrid, Spain
[3] Hosp 12 Octubre, Dept Urol, E-28041 Madrid, Spain
关键词
D O I
10.1097/00007890-200005270-00015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The age limit of the cadaver kidney donors is increasing in response to the growing demand for renal transplantation. Simultaneous double kidney transplantation (SDKT) with kidneys obtained from elderly adults has been proposed to increase the transplantation number and improve its results. However, if SDKT is performed when there are no clear indications, a negative effect could be produced on the total number of transplanted patients as both kidneys would be used for only one recipient. Material and Methods. In December 1996 we designed a transplantation protocol to be able to extend the selection of cadaver kidney donors with normal serum creatinine levels without establishing any age limit. A pregraft renal biopsy was always performed to analyze the glomerulosclerosis (GE) percentage whenever the donors were 60 gears of age or older. A SDKT was performed in a single recipient when the donor age was 75 years or older or when the donors between 60 and 74 years old had a GE rate of more than 15%. On the contrary, a single kidney transplantation was performed in two different recipients for kidneys from donors between 60 and 74 years of age with a GE rate of less than 15%. Kidneys having GE rates of more than 50% were discarded for transplantation. Donor kidneys from subjects younger than 60 years of age were always used for a single kidney transplantation. Results. Eased on the above mentioned protocol, from December 1996 to May 1998, 181 patients received a kidney transplantation in our hospital, These patients were divided into three groups: group I which included the SDKT recipients (n=21), group II or single kidney recipients from 60- to 74-year-old donors (n=40), and group III or recipients from <60-year-old donors (n=120). The mean follow-up time was 15+/-5 months (range 6-24). Mean donor age was 75+/-7 years in group I, this was significantly higher than in group II (67+/-4, P<0.001) and group III (37+/-15, P<0.001). The primary nonfunction rate was low in the three groups, there being no statistically significant differences (5, 5, and 4%, respectively). A significantly greater percentage of patients from group I (76%) presented immediate renal graft function as compared with group II (43% P<0.01) and III (50%, P<0.05). The acute rejections rate was very low in all three groups (9.5, 7.5, and 22%, respectively) with significant differences between groups II and III (P<0.05). No significant differences between the different groups were observed for one year actuarial patient survival (100, 95, and 98%, respectively) or graft survival rates (95, 90, and 93%, respectively). The 6-month serum creatinine levels were excellent in the three groups, although there were significant differences between groups I and II (1.6+/-0.3 vs. 1.9+/-0.6 mg/dl, P<0.05), II and III (1.9+/-0.6 vs. 1.4+/-0.4 mg/dl, P<0.001), and I and III (P<0.05). Conclusions. Simultaneous double kidney transplantations make it possible to use kidneys from extremely elderly donors (>75 years) or those whose GE>15%, In addition, kidneys from donor 60-74 years old in which the GE<15% can be used for single kidney transplantations in two different recipients with excellent results.
引用
收藏
页码:2060 / 2066
页数:7
相关论文
共 36 条
[1]   EFFECT OF DONOR AGE ON OUTCOME OF KIDNEY-TRANSPLANTATION - A 2-YEAR ANALYSIS OF TRANSPLANTS REPORTED TO THE UNITED-NETWORK-FOR-ORGAN-SHARING-REGISTRY [J].
ALEXANDER, JW ;
BENNETT, LE ;
BREEN, TJ .
TRANSPLANTATION, 1994, 57 (06) :871-876
[2]   When should expanded criteria donor kidneys be used for single versus dual kidney transplants? [J].
Alfrey, EJ ;
Lee, CM ;
Scandling, JD ;
Pavlakis, M ;
Markezich, AJ ;
Dafoe, DC .
TRANSPLANTATION, 1997, 64 (08) :1142-1146
[3]   RISK-FACTORS FOR CHRONIC REJECTION IN RENAL-ALLOGRAFT RECIPIENTS [J].
ALMOND, PS ;
MATAS, A ;
GILLINGHAM, K ;
DUNN, DL ;
PAYNE, WD ;
GORES, P ;
GRUESSNER, R ;
NAJARIAN, JS ;
FERGUSON ;
PAUL ;
SCHAFFER .
TRANSPLANTATION, 1993, 55 (04) :752-757
[4]  
Andrés A, 1998, NEFROLOGIA, V18, P50
[5]  
ANDREU J, 1992, TRANSPLANT P, V24, P120
[6]  
BRENNER BM, 1992, J AM SOC NEPHROL, V3, P162
[7]  
CAMPISTOL JM, 1989, LANCET, V2, P744
[8]  
CECKA JM, 1995, TRANSPLANT P, V27, P801
[9]  
CHERTOW GM, 1995, NONINMUNOLOGIC PREDI, V48, pS48
[10]  
COFAN F, 1995, TRANSPLANT P, V27, P2248